George Fennell sold $4.6M of IDXX
Executive Vice President at IDEXX LABORATORIES INC /DE. 9,986 shares at an average of $462.53, traded Feb 10, 2025, filed Feb 11, 2025.
Score components
- +15RoleOfficer
- +25Trade size$4.6M at market
- +20Share of holdings soldSold 55% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874716-25-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 7, 2025 | MOption exercise Common Stock | +1,256 | $79.54 | $100k | 8,176 | Feb 11, 2025 |
| Feb 10, 2025 | MOption exercise Common Stock | +9,986 | $79.54 | $794k | 18,162 | Feb 11, 2025 |
| Feb 10, 2025 | SOpen-market sale Common Stock | -9,986 | $462.53 | $4.6M | 8,176 | Feb 11, 2025 |
| Feb 7, 2025 | MOption exercise Incentive Stock Option (right-to-buy)derivative | -1,256 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 10, 2025 | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -9,986 | $0.00 | $0 | 0 | Feb 11, 2025 |
Related signals
Other insiders at IDEXX LABORATORIES INC /DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | IDXXsell IDEXX LABORATORIES INC /DE | Lawrence D Kingsley director | $1.2M 2,203 shares | -19% | |
| 60Notable | IDEXX LABORATORIES INC /DE | M Anne Szostak director | $1.2M 2,306 shares | -176% | |
| 50Moderate | IDEXX LABORATORIES INC /DE | Daniel M Junius director | $1.4M 2,683 shares | -45% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Sophie V. Vandebroek director | $628k 1,279 shares | -52% | |
| 58Moderate | IDEXX LABORATORIES INC /DE | M Anne Szostak director | $1.4M 3,000 shares | -49% | |
| 36Weak | IDXXsell IDEXX LABORATORIES INC /DE | Sophie V. Vandebroek director | $145k 344 shares | -28% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.